Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 3.08 B3.18 B3.28 B3.48 B3.47 B 13.4 B Research & development ————— — Operating income 812 M494 M2.03 B1.04 B755 M 4.32 B Non-Operating Income, Total -1.08 B-2.06 B-1.39 B-1.08 B-724 M -5.25 B Interest expense, net of interest capitalized ————— — Non-Operating Income, excl. Interest Expenses -1.08 B-2.06 B-1.39 B-1.08 B-724 M -5.25 B Unusual income/expense ————— — Pretax income 949 M761 M1.86 B1.21 B735 M 4.57 B Equity in earnings 29 M21 M83 M-4 M2 M 102 M Taxes 207 M195 M382 M269 M129 M 975 M Non-controlling/minority interest 35 M33 M52 M—9 M — After tax other income/expense ————— — Net income before discontinued operations 707 M533 M1.43 B905 M597 M 3.47 B Discontinued operations ————— — Net income 707 M533 M1.43 B905 M597 M 3.47 B Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders 697 M527 M1.42 B895 M588 M 3.43 B Basic earnings per share (Basic EPS) 1.971.494.032.561.69 9.77 Diluted earnings per share (Diluted EPS) 1.961.484.012.541.68 9.71 Average basic shares outstanding 354.3 M353.1 M351.1 M351.8 M347.7 M — Diluted shares outstanding 356.1 M354.9 M353 M353.7 M349.4 M — EBITDA 1.22 B901 M1.89 B989 M898 M 4.68 B EBIT 812 M494 M2.03 B1.04 B755 M 4.32 B Cost of revenue 9.57 B10.06 B12.58 B10.97 B11.3 B 44.91 B Other cost of goods sold ————— — Depreciation & amortization (cash flow) 407 M407 M-144 M-49 M143 M 357 M